Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thymoglobulin Induction in Liver Transplant
NCT00117689Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2005
- Primary completion
- Dec 2007
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of antithymocyte globulin in Liver transplant rejection, sponsored by Sanofi. Started Apr 2005; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
Liver transplant rejection
Beyond the preview
Go deeper on NCT00117689.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00117689.